The Wall Street Journal reports on a new drug company scheme in the UK.
Under the guise of "disease management programs," the paper says that drug companies are paying for nurses in doctors' offices to study patient charts to find people with chronic illnesses - which may often lead to a new prescription of a drug made by the company funding the nurses.
Posted by schwitz at May 30, 2007 08:55 AM | TrackBack